Credit Suisse Ag I Bio, Inc. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $4,333 - $8,666	-18,841 Reduced 99.99%	1 $0
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $3,481 - $7,078	-11,604 Reduced 38.11%	18,842 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $16,745 - $31,663	30,446 New	30,446 $16,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $30,686 - $41,502	-25,153 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.18 - $2.62 $29,568 - $65,651	-25,058 Reduced 49.91%	25,153 $39,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.24 $52,721 - $112,472	50,211 New	50,211 $52,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.